Clinical data, including results from the March 2026 Phase 3 TRANSCEND-T2D-1 trial, suggests that retatrutide exhibits properties relevant to weight regulation and glycemic modulation in research models
American Diabetes Association, 79th Scientific Sessions 2019
Int J Mol Med 47:11071156 Lohrasbi P, Karbalay DS, Tabei SMB, Azarpira N, Alaee S, Rafiee B, Bahmanpour S (2022) Melatonin & metformin in PCOS mice
Your Concierge Support A licensed clinician, matched to you
These drugs could achieve weight loss approaching or exceeding 25%, further transforming treatment expectations
L-carnitine: Participants were treated with Carnitor brand or generics at a starting dose of 100 mg/kg/day divided BID, or 2 grams twice a day, whichever is smaller